Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study
在患有非典型溶血性尿毒综合征且肾脏功能正常的患者中，早期停用依库珠单抗是安全且具有成本效益的：CUREiHUS 研究结果
期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2022.10.013
Bouwmeester, Romy N; Duineveld, Caroline; Wijnsma, Kioa L; Bemelman, Frederike J; van der Heijden, Joost W; van Wijk, Joanna A E; Bouts, Antonia H M; van de Wetering, Jacqueline; Dorresteijn, Eiske; Berger, Stefan P; Gracchi, Valentina; van Zuilen, Arjan D; Keijzer-Veen, Mandy G; de Vries, Aiko P J; van Rooij, Roos W G; Engels, Flore A P T; Altena, Wim; de Wildt, Renée; van Kempen, Evy; Adang, Eddy M; Ter Avest, Mendy; Ter Heine, Rob; Volokhina, Elena B; van den Heuvel, Lambertus P W J; Wetzels, Jack F M; van de Kar, Nicole C A J
